Delhi High Court quashes Cipla's appeal, can't market generics of Novartis' Onbrez
Thursday, March 9, 2017, 5:35 PM
Onbrez, Novartis' brand of the chemical drug indacaterol, is used to treat chronic obstructive pulmonary disease (COPD). Indian drug maker Lupin Ltd imports and markets Onbrez here through a 2012 agreement with Novartis. Justices Badar Durrez Ahmed and Sanjeev Sachdeva on Thursday dismissed Cipla's appeal to an earlier ruling by the Delhi High Court on several grounds.